Early and adequate antibiotic therapy in the treatment of severe sepsis and septic shock

被引:25
作者
Dickinson J.D. [1 ]
Kollef M.H. [1 ]
机构
[1] Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, Campus Box 8052, St. Louis, MO 63110
关键词
Antibiotic bundles; Combination antibiotics; Early antibiotics; Fungal infections; Inappropriate antibiotics; Multi-drug resistant organisms; Septic shock; Severe sepsis;
D O I
10.1007/s11908-011-0206-8
中图分类号
学科分类号
摘要
Severe sepsis and septic shock are conditions that pose difficult challenges to physicians and the health care system. In the past 10 years, a number of retrospective and prospective observational studies have shed light on the importance of a rapid and systematic approach to treatment of these conditions. A key component is early and appropriate use of antibiotics. Delay of even 6 h can dramatically increase hospital mortality. In addition, multivariate analyses have demonstrated that inappropriate initial antibiotics lead to worse outcomes. The treating physician can rapidly identify risk factors for initial inappropriate antibiotics at the bedside, such as recent antibiotic therapy or recent hospitalization. Organized antibiotic order sets have been shown to significantly improve timely appropriate antibiotic administration in septic patients. Finally, emerging laboratory data suggest that early in the course of septic shock, the pharmacokinetics of common broad spectrum antibiotics may be significantly altered due to increased volumes of distribution having dosing implications for antibiotics in septic shock. © 2011 Springer Science+Business Media, LLC.
引用
收藏
页码:399 / 405
页数:6
相关论文
共 50 条
[1]  
Dellinger R.P., Zimmerman J.L., Vincent J.L., Et al., Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2008, Crit Care Med, 36, pp. 296-327, (2008)
[2]  
Vincent J.L., Korkut H.A., Defining sepsis, Clin in Chest Med, 29, pp. 585-590, (2008)
[3]  
Alberti C., Brun-Buisson C., Burchardi H., Martin C., Goodman S., Artigas A., Sicignano A., Palazzo M., Moreno R., Boulme R., Lepage E., Le Gall J., Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study, Intensive Care Medicine, 28, 2, pp. 108-121, (2002)
[4]  
Vincent J.-L., Sakr Y., Sprung C.L., Ranieri V.M., Reinhart K., Gerlach H., Moreno R., Carlet J., Le Gall J.-R., Payen D., Sepsis in European intensive care units: Results of the SOAP study, Critical Care Medicine, 34, 2, pp. 344-353, (2006)
[5]  
Martin G.S., Mannino D.M., Eaton S., Moss M., The epidemiology of sepsis in the United States from 1979 through 2000, New England Journal of Medicine, 348, 16, pp. 1546-1554, (2003)
[6]  
Dombrovskiy V.Y., Martin A.A., Sunderram J., Paz H.L., Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: A trend analysis from 1993 to 2003, Critical Care Medicine, 35, 5, pp. 1244-1250, (2007)
[7]  
Angus D., Wax R., Epidemiology of sepsis: An update, Crit Care Med, 29, (2001)
[8]  
Burchardi H., Schneider H., Economic aspects of severe sepsis: A review of intensive care unit costs, cost of illness and cost effectiveness of therapy, PharmacoEconomics, 22, 12, pp. 793-813, (2004)
[9]  
Shorr A.F., Micek S.T., Jackson Jr. W.L., Kollef M.H., Economic implications of an evidence-based sepsis protocol: Can we improve outcomes and lower costs?, Critical Care Medicine, 35, 5, pp. 1257-1262, (2007)
[10]  
Otero R.M., Nguyen B., Huang D.T., Gaieski D.F., Goyal M., Gunnerson K.J., Trzeciak S., Sherwin R., Holthaus C.V., Osborn T., Rivers E.P., Early goal-directed therapy in severe sepsis and septic shock revisited: Concepts, controversies, and contemporary findings, Chest, 130, 5, pp. 1579-1595, (2006)